Please try another search
| Name | Net % | Long % | Short % |
|---|---|---|---|
| Cash | 7.410 | 7.410 | 0.000 |
| Shares | 94.280 | 94.280 | 0.000 |
| Ratios | Value | Category Average |
|---|---|---|
| P/E Ratio | 26.463 | 16.115 |
| Price to Book | 5.071 | 2.484 |
| Price to Sales | 1.886 | 1.992 |
| Price to Cash Flow | 37.394 | 12.341 |
| Dividend Yield | 0.468 | 2.243 |
| 5 Years Earnings Growth | 2.173 | 9.836 |
| Name | Net % | Category Average |
|---|---|---|
| Healthcare | 99.800 | 18.256 |
| Financial Services | 0.150 | 11.512 |
| Consumer Cyclical | 0.050 | 22.961 |
Number of long holdings: 39
Number of short holdings: 1
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| Duality Biotherapeutics | KYG2929M1087 | 17.27 | 289.40 | -3.21% | |
| Sichuan Kelun Biotech | CNE1000062J1 | 11.03 | 437.60 | +2.48% | |
| Innovent Biologics | KYG4818G1010 | 8.75 | 85.55 | +0.53% | |
| Hutchison China | KYG4672N1198 | 6.72 | 227.00 | -0.87% | |
| Keymed Biosciences Inc | - | 6.57 | - | - | |
| 3SBio | KYG8875G1029 | 5.90 | 27.98 | +3.17% | |
| Innocare | KYG4783B1032 | 4.65 | 13.84 | +0.95% | |
| CSPC Pharma | HK1093012172 | 3.92 | 7.89 | -3.90% | |
| Akeso | KYG0146B1032 | 3.82 | 115.20 | +0.26% | |
| Remegen | CNE1000048G6 | 3.42 | 84.55 | +3.24% |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| China Universal Consumer Industries | 9.98B | 6.47 | -5.92 | 10.14 | ||
| China Universal Selective Mixed Sec | 8.48B | 24.52 | 3.89 | 7.83 | ||
| China Universal Healthcare Serv mix | 4.11B | 61.96 | 10.79 | 8.89 | ||
| China Universal Blue Chip Equity Fu | 3.9B | 26.52 | 2.32 | 9.40 | ||
| China Universal Focus Growth Fund | 2.85B | 25.00 | -3.64 | 7.52 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review